Nifedipine Tablet, Extended Release
Product Images NDC 70518-3520

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Nifedipine (NDC 70518-3520). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Nifedipine 60 mg extended-release oral tablets packaging label showing a quantity of 30 tablets. The label includes the NDC 70518-3520-00 and states the product is repackaged by RemedyRepack Inc. It also provides storage instructions and manufacturer information, with a purple color accent behind the strength.*

FDA Label Image

01 (Image 01)

Chemical structure of nifedipine, showing its molecular arrangement including nitro and acetate functional groups attached to a dihydropyridine ring with a phenyl substituent.*

FDA Label Image

02 (Image 02)

A data table comparing adverse effects percentages between patients taking Nifedipine extended-release tablets (N=707) and a placebo group (N=266). Reported adverse effects include headache, fatigue, dizziness, constipation, and nausea with corresponding percentage values for each group.*

FDA Label Image

03 (Image 03)

A data table listing adverse effects reported for Nifedipine Capsules compared to placebo. It shows percentages for each adverse effect, including dizziness, flushing, headache, weakness, nausea, muscle cramps, peripheral edema, nervousness, palpitations, respiratory symptoms, and nasal congestion, for groups of 226 and 235 subjects respectively.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.